| J9271 | Injection, pembrolizumab, 1 mg | 13,200 | $40 | $567.6K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 11,700 | $40 | $444.6K |
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 140 | $1,110 | $156.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,970 | $60 | $120.2K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 3,490 | $30 | $118.7K |
| J0897 | Injection, denosumab, 1 mg | 5,520 | $20 | $99.4K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 72,750 | $1 | $72.8K |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 7,000 | $10 | $70K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 60 | $1,080 | $67.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 650 | $90 | $57.7K |